Intellectual Property Position
INTER-K's owns all right, title and interest in its patent portfolio, which has been formulated to provide comprehensive protection for the novel integrin 
- ERK2 cell signalling paradigm together with its anti-cancer lead compound:
International (PCT) Application No. : PCT/AU00/00729
Priority Details : PQ 1248 filed 28.06.99, PQ 8003 filed 06.06.00
Title : A method of modulating integrin mediated cellular activity
| Country / Region |
Application/Patent # |
Status |
| AU |
781540 |
Granted |
| AU |
2005204275 |
Granted |
| US |
10/019816 |
Pending |
| EP |
1196449 |
Granted |
International (PCT) Application No. : PCT/AU01/01672
Priority Details : PR 2305 filed 22.12.00
Title : MAP Kinase integrin binding domain
| Country / Region |
Application/Patent # |
Status |
| AU |
2001297809 |
Granted |
| US |
7422883 |
Granted |
| EP |
01271913.4 |
Pending |
International (PCT) Application No. : PCT/AU2004/001416
Priority Details : 2003905726
Title : Methods and agents for treatment of cancer
| Country / Region |
Application/Patent # |
Status |
| AU |
2004281077 |
Pending |
| US |
10/575,736 |
Pending |
| EP |
04789583.4 |
Pending |
| UK |
2409679 |
Granted |
International (PCT) Application # PCT/AU2009/000201 "Therapeutic Peptides" was filed on 23rd February 2009
European Patent Application“A method for modulating integrin mediated cellular activity” granted 2008
US Patent Application “MAP Kinase-integrin binding domain” granted 2008
United Kingdom Application“Methods and agents for the treatment of cancer” granted 2005
Australian Patent Application“A method for modulating integrin mediated cellular activity” granted 2005
Australian Patent Application
“A method for modulating integrin mediated cellular activity” granted 2005
Australian Divisional Patent Application
“A method for modulating integrin mediated cellular activity” granted 2008
Australian Patent Application
“MAP kinase integrin binding domain” granted 2007
Australian Provisional Patent Applications and PCT“Peptide anti-viral therapy” filed 2008
“Therapeutic peptides” PCT filed 2009
“Treatment of cancer” filed 2009
“Inhibition of Cancer” filed 2009
“Anti-cancer peptides” filed 2009